FR2450814A1 - 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit - Google Patents

24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit

Info

Publication number
FR2450814A1
FR2450814A1 FR8004852A FR8004852A FR2450814A1 FR 2450814 A1 FR2450814 A1 FR 2450814A1 FR 8004852 A FR8004852 A FR 8004852A FR 8004852 A FR8004852 A FR 8004852A FR 2450814 A1 FR2450814 A1 FR 2450814A1
Authority
FR
France
Prior art keywords
hydroxycholecalciferol
difluoro
calcium
vitamin
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8004852A
Other languages
English (en)
Other versions
FR2450814B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of FR2450814A1 publication Critical patent/FR2450814A1/fr
Application granted granted Critical
Publication of FR2450814B1 publication Critical patent/FR2450814B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE L'INDUSTRIE PHARMACEUTIQUE. ELLE A POUR OBJET UN NOUVEAU DERIVE DE LA VITAMINE D, A SAVOIR LE 24,24-DIFLUORO-25-HYDROXYCHOLECALCIFEROL. CE COMPOSE MANIFESTE UNE ACTIVITE VITAMINOIDE D PAR SA CAPACITE D'AUGMENTER LE TRANSPORT INTESTINAL DU CALCIUM, D'ELEVER LA CONCENTRATION DU SERUM EN CALCIUM ET EN PHOSPHORE INORGANIQUE ET D'EMPECHER L'APPARITION DU RACHITISME. CE COMPOSE EST PREFERE POUR REMPLACER LA VITAMINE D DANS LE TRAITEMENT D'AFFECTIONS OU SE MANIFESTE UN DESEQUILIBRE CALCIUM-PHOSPHORE ET SUR LESQUELLES UN TRAITEMENT PAR LA VITAMINE D EST INOPERANT.
FR8004852A 1979-03-05 1980-03-04 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit Expired FR2450814B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/017,168 US4196133A (en) 1979-03-05 1979-03-05 24,24-Difluoro-25-hydroxycholecalciferol

Publications (2)

Publication Number Publication Date
FR2450814A1 true FR2450814A1 (fr) 1980-10-03
FR2450814B1 FR2450814B1 (fr) 1986-04-11

Family

ID=21781101

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8004852A Expired FR2450814B1 (fr) 1979-03-05 1980-03-04 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
FR8018944A Granted FR2455609A1 (fr) 1979-03-05 1980-09-02 24-24-difluoro-25-hydroxycholecalciferol

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8018944A Granted FR2455609A1 (fr) 1979-03-05 1980-09-02 24-24-difluoro-25-hydroxycholecalciferol

Country Status (16)

Country Link
US (1) US4196133A (fr)
JP (2) JPS6310946B2 (fr)
AU (1) AU532388B2 (fr)
BE (1) BE882036A (fr)
CA (1) CA1157049A (fr)
CH (2) CH654015A5 (fr)
DK (3) DK156635C (fr)
FR (2) FR2450814B1 (fr)
GB (1) GB2044770B (fr)
IE (1) IE49532B1 (fr)
IL (1) IL58525A (fr)
IT (1) IT1151077B (fr)
NL (1) NL7920160A (fr)
NZ (1) NZ191899A (fr)
SE (1) SE8007427L (fr)
WO (1) WO1980001915A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4254045A (en) * 1980-04-21 1981-03-03 Wisconsin Alumni Research Foundation 1α-Hydroxy-2β-fluorocholecalciferol
US4307025A (en) * 1981-02-17 1981-12-22 Wisconsin Alumni Research Foundation 1α, 25-dihydroxy-2β-fluorovitamin D3
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
IT1175607B (it) * 1983-08-18 1987-07-15 Wisconsin Alumni Res Found 23,23-difluoro-25-idrossi-e 1 alfa, 25-diidrossi-vitamina d3
US4500460A (en) * 1983-08-18 1985-02-19 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
US4564474A (en) * 1983-08-18 1986-01-14 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
JPS6253960A (ja) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd ビタミンｄ↓３の誘導体
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327790A1 (fr) * 1975-10-14 1977-05-13 Merck & Co Inc Derives bloques de cholecalciferol et de dihydrotachysterol3
FR2453151A1 (fr) * 1979-02-16 1980-10-31 Yamada Sachiko Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4028349A (en) * 1976-03-08 1977-06-07 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof
JPS595432B2 (ja) * 1976-11-09 1984-02-04 凸版印刷株式会社 容器の製造方法
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2327790A1 (fr) * 1975-10-14 1977-05-13 Merck & Co Inc Derives bloques de cholecalciferol et de dihydrotachysterol3
FR2453151A1 (fr) * 1979-02-16 1980-10-31 Yamada Sachiko Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/79 *

Also Published As

Publication number Publication date
CA1157049A (fr) 1983-11-15
FR2455609B1 (fr) 1983-07-01
FR2450814B1 (fr) 1986-04-11
GB2044770B (en) 1983-05-11
IL58525A0 (en) 1980-01-31
IL58525A (en) 1983-02-23
DK425183A (da) 1983-09-19
WO1980001915A1 (fr) 1980-09-18
DK425183D0 (da) 1983-09-19
DK156635C (da) 1990-02-12
AU5580980A (en) 1980-09-11
DK156644B (da) 1989-09-18
DK446482A (da) 1982-10-08
DK156726C (da) 1990-03-05
DK156635B (da) 1989-09-18
DK156644C (da) 1990-02-12
JPS56500064A (fr) 1981-01-22
CH653018A5 (de) 1985-12-13
IT1151077B (it) 1986-12-17
US4196133A (en) 1980-04-01
GB2044770A (en) 1980-10-22
IE800420L (en) 1980-09-05
CH654015A5 (de) 1986-01-31
JPH0142944B2 (fr) 1989-09-18
AU532388B2 (en) 1983-09-29
DK467780A (da) 1980-11-04
NZ191899A (en) 1984-11-09
JPS63183559A (ja) 1988-07-28
DK156726B (da) 1989-09-25
NL7920160A (nl) 1980-12-31
SE8007427L (sv) 1980-10-22
IE49532B1 (en) 1985-10-16
JPS6310946B2 (fr) 1988-03-10
FR2455609A1 (fr) 1980-11-28
IT8020326A0 (it) 1980-03-03
BE882036A (fr) 1980-07-01

Similar Documents

Publication Publication Date Title
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
FR2450814A1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
FR2422679A1 (fr) Fabrication de support tridimensionnel comprenant un mineral poreux et un produit de polymerisation reactif, notamment pour liaison de substances biologiquement actives
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
PT67365A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
LU78113A1 (fr) Nouveaux acides 5-alkoxyimidazo(1,2-a)quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant ainsi qu'un procede pour leur preparation
FR2433514A1 (fr) Composes fluores ayant la structure de la vitamine d
MA21586A1 (fr) Procede de preparition d'une nouvelle forme pharmaceutique a liberation prolongee comprenant un complexe resine principe actif.
FR2452481A1 (fr) 24,24-difluoro-1a,25-dixydroxycholecalciferol et composition pharmaceutique renfermant ce produit
PT66850B (fr) Procede pour la preparation d'une composition pharmaceutique
FR2556218B1 (fr) Produit pharmaceutique pour application locale constitue par l'association d'un principe actif medicamenteux-agent enzymatique
FR2394526A1 (fr) Mercaptoacetylamidobenzoylglycine et procede therapeutique de mucolyse
PT66120A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT65436A (fr) Procede pour la preparation de nouveaux composes organiques en effet pharmaceutique
FR2446831A1 (fr) Derive oxyimino-e-homo-eburnane, procede pour le preparer et son utilisation dans une composition pharmaceutique pour la preparation de derives ester de l'acide apovincaminique
PT65264B (fr) Procede pour la preparation d'une composition pharmaceutique contenant des composes organiques
FR2447377A1 (fr) 25-hydroxycholecalciferol-26,23-lactone et composition pharmaceutique renfermant ce produit
BE902055A (fr) Preparations pharmaceutiques.
FR2400505A1 (fr) 1-phenylethanolamines anti-inflammatoires, compositions pharmaceutiques en comprenant et procedes pour les produire
BE758122A (fr) Procede pour la fabrication d'une preparation pharmaceutique
FR2354097A1 (fr) Composition therapeutique de derives thiazoliques et sa preparation
BE819891A (fr) Composition pharmaceutique pour le traitement de l'arthrite contenant un derive d'acide fusidique
PT64942A (fr) Procede pour la preparation nouveaux composes organiques en effet pharmaceutique
PT65539A (fr) Procede pour la preparation d'une nouvelle composition organique a effet pharmaceutique
PT65435A (fr) Procede pour la production de nouveaux composes organiques en effet pharmaceutique

Legal Events

Date Code Title Description
ST Notification of lapse